Boston Scientific Corp. (NYSE: BSX) kicked off on Monday, up 1.02% from the previous trading day, before settling in for the closing price of $67.33. Over the past 52 weeks, BSX has traded in a range of $48.35-$69.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 8.10%. While this was happening, its average annual earnings per share was recorded 10.16%. With a float of $1.46 billion, this company’s outstanding shares have now reached $1.47 billion.
Let’s determine the extent of company efficiency that accounts for 48000 employees.
Boston Scientific Corp. (BSX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Boston Scientific Corp. is 0.45%, while institutional ownership is 93.82%. The most recent insider transaction that took place on Apr 01 ’24, was worth 1,133,069. In this transaction EVP, Global Operations of this company sold 16,351 shares at a rate of $69.30, taking the stock ownership to the 50,638 shares. Before that another transaction happened on Apr 01 ’24, when Company’s EVP, Human Resources sold 6,983 for $68.42, making the entire transaction worth $477,777. This insider now owns 51,068 shares in total.
Boston Scientific Corp. (BSX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2023, the organization reported $0.55 earnings per share (EPS), higher than consensus estimate (set at $0.51) by $0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.28% during the next five years compared to -2.05% drop over the previous five years of trading.
Boston Scientific Corp. (NYSE: BSX) Trading Performance Indicators
Take a look at Boston Scientific Corp.’s (BSX) current performance indicators. Last quarter, stock had a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.02. Likewise, its price to free cash flow for the trailing twelve months is 55.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.07, a number that is poised to hit 0.51 in the next quarter and is forecasted to reach 2.55 in one year’s time.
Technical Analysis of Boston Scientific Corp. (BSX)
Looking closely at Boston Scientific Corp. (NYSE: BSX), its last 5-days average volume was 6.67 million, which is a jump from its year-to-date volume of 6.39 million. As of the previous 9 days, the stock’s Stochastic %D was 26.45%. Additionally, its Average True Range was 1.06.
During the past 100 days, Boston Scientific Corp.’s (BSX) raw stochastic average was set at 92.21%, which indicates a significant increase from 50.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 11.75% in the past 14 days, which was lower than the 15.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $67.23, while its 200-day Moving Average is $57.59. However, in the short run, Boston Scientific Corp.’s stock first resistance to watch stands at $68.82. Second resistance stands at $69.61. The third major resistance level sits at $70.62. If the price goes on to break the first support level at $67.01, it is likely to go to the next support level at $66.00. Now, if the price goes above the second support level, the third support stands at $65.21.
Boston Scientific Corp. (NYSE: BSX) Key Stats
The company with the Market Capitalisation of 99.98 billion has total of 1,467,096K Shares Outstanding. Its annual sales at the moment are 14,240 M in contrast with the sum of 1,591 M annual income. Company’s last quarter sales were recorded 3,725 M and last quarter income was 503,000 K.
